MRSN - Mersana Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRSN is currently covered by 8 analysts with an average price target of $8.01. This is a potential upside of $5.84 (269.12%) from yesterday's end of day stock price of $2.17.

Mersana Therapeutics's activity chart (see below) currently has 36 price targets and 41 ratings on display. The stock rating distribution of MRSN is 58.82% BUY and 41.18% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 32.78% with an average time for these price targets to be met of 248.92 days.

Highest price target for MRSN is $9, Lowest price target is $5, average price target is $8.01.

Most recent stock forecast was given by ASHIK KURIAN from CITI on 15-Nov-2024. First documented stock forecast 24-Jul-2017.

Currently out of the existing stock ratings of MRSN, 10 are a BUY (58.82%), 7 are a HOLD (41.18%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$5

$2.96 (145.10%)

$1

11 days ago
(15-Nov-2024)

0/4 (0%)

$2.65 (112.77%)

Buy

$7

$4.96 (243.14%)

$2

8 months 28 days ago
(29-Feb-2024)

3/6 (50%)

$1.56 (28.68%)

191

Buy

$9

$6.96 (341.18%)

8 months 28 days ago
(29-Feb-2024)

0/2 (0%)

$3.56 (65.44%)

Buy

$7

$4.96 (243.14%)

$14

8 months 28 days ago
(29-Feb-2024)

1/3 (33.33%)

$1.56 (28.68%)

1072

Hold

$5

1 years 3 months 30 days ago
(27-Jul-2023)

2/3 (66.67%)

$1.46 (19.97%)

48

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRSN (Mersana Therapeutics) average time for price targets to be met?

On average it took 248.92 days on average for the stock forecasts to be realized with a an average price target met ratio 32.78

Which analyst has the current highest performing score on MRSN (Mersana Therapeutics) with a proven track record?

MICHAEL ULZ

Which analyst has the most public recommendations on MRSN (Mersana Therapeutics)?

Michael Ulz works at MORGAN STANLEY and has 4 price targets and 3 ratings on MRSN

Which analyst is the currently most bullish on MRSN (Mersana Therapeutics)?

Michael Ulz with highest potential upside - $25.74

Which analyst is the currently most reserved on MRSN (Mersana Therapeutics)?

Jessica Fye with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?